Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

PHIBRO ANIMAL HEALTH CORP

PAHC · Nasdaq · CIK 0001069899 · Healthcare · Drug Manufacturers—Specialty & Generic

INSIDER SIGNAL

No active buy signal

1 qualifying P purchase group
in the current 180-day scoring window

36 Form 4 transaction lines observed in the same window
19 sales · 16 option, withholding, award, gift or other lines

Last qualifying purchase2026-05-29 · CORCORAN E THOMAS · $317.7K

WHY NO ACTIVE SIGNAL?

Purchase activityPresent
Recent buying1 qualifying line group(s)
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
BENDHEIM JACK; BFI Co., LLCPresident and CEO
▼▼▼▼▼▼▼▼▼○○
David GlennChief Financial Officer
○○○
Miller Larry LeeChief Operating Officer
○○○
Weinstein JudithSee Remarks
○○
Escudero Lisa AnnSee Remarks
○○
Bendheim Daniel MPresident and CEO
○○
● Purchase▼ Sale○ Other

Showing the six most active owners; 3 additional owner(s) remain in Form 4 evidence.

Purchase breadth & concentration

QUALIFYING BUYERS1
PURCHASE CONCENTRATION100%Largest buyer: CORCORAN E THOMAS · $317.7K
CLUSTER BUYING · 15D1 insiderPeak activity: 2026-05-29–2026-05-29

Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-05-29 · CORCORAN E THOMAS.

Recent Form 4 activity

1Purchases
116Sales
29Other Form 4 lines
51SEC filings · 365 days
BUYING1 qualifying P line(s) · 180 days
SELLING19 sale line(s) · context only
OTHER16 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
1,020,961
Previous report
1,142,218
Avg daily volume
251,629
Days to cover
4.1

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-05-29CORCORAN E THOMASPurchase (P)Class A Common Stock10,000USD 31.77USD 317,700SEC filing ↗
2025-02-24CORCORAN E THOMASPurchase (P)Class A Common Stock5,000USD 22.10USD 110,500SEC filing ↗
2024-09-04CORCORAN E THOMASPurchase (P)Class A Common Stock5,000USD 20.02USD 100,100SEC filing ↗
2021-08-30CORCORAN E THOMASPurchase (P)Class A Common Stock5,000USD 23.68USD 118,400SEC filing ↗

Form 4 evidence

146 transaction lines in the latest 365-day window; 167 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-06Miller Larry LeeAward / grant (A)Class A Common Stock3,726USD 0.00USD 0SEC filing ↗
2026-08-06David GlennAward / grant (A)Class A Common Stock3,482USD 0.00USD 0SEC filing ↗
2026-08-06Weinstein JudithAward / grant (A)Class A Common Stock2,478USD 0.00USD 0SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-06Miller Larry LeeAward / grant (A)Class A Common Stock3,726USD 0.00USD 0SEC filing ↗
2026-08-06David GlennAward / grant (A)Class A Common Stock3,482USD 0.00USD 0SEC filing ↗
2026-08-06Weinstein JudithAward / grant (A)Class A Common Stock2,478USD 0.00USD 0SEC filing ↗
2026-08-06Rodriguez PatrickAward / grant (A)Class A Common Stock1,503USD 0.00USD 0SEC filing ↗
2026-08-06Miller Larry LeeAward / grant (A)Class A Common Stock3,522USD 0.00USD 0SEC filing ↗
2026-08-06Escudero Lisa AnnAward / grant (A)Class A Common Stock1,547USD 0.00USD 0SEC filing ↗
2026-08-06David GlennAward / grant (A)Class A Common Stock3,334USD 0.00USD 0SEC filing ↗
2026-08-06Bendheim Daniel MAward / grant (A)Class A Common Stock11,699USD 0.00USD 0SEC filing ↗
2026-08-06BENDHEIM JonathanAward / grant (A)Class A Common Stock2,716USD 0.00USD 0SEC filing ↗
2026-08-06BENDHEIM JACK; BFI Co., LLCAward / grant (A)Class A Common Stock12,103USD 0.00USD 0SEC filing ↗
2026-08-04Weinstein JudithJ (J)Class A Common Stock472USD 36.60USD 17,275SEC filing ↗
2026-08-04Miller Larry LeeJ (J)Class A Common Stock635USD 36.60USD 23,241SEC filing ↗
2026-08-04Escudero Lisa AnnJ (J)Class A Common Stock265USD 36.60USD 9,699SEC filing ↗
2026-08-04David GlennJ (J)Class A Common Stock840USD 36.60USD 30,744SEC filing ↗
2026-08-04Bendheim Daniel MJ (J)Class A Common Stock486USD 36.60USD 17,788SEC filing ↗
2026-08-04BENDHEIM JACK; BFI Co., LLCJ (J)Class A Common Stock2,303USD 36.60USD 84,290SEC filing ↗
2026-05-29CORCORAN E THOMASPurchase (P)Class A Common Stock10,000USD 31.77USD 317,700SEC filing ↗
2026-05-07BENDHEIM JACK; BFI Co., LLCSale (S)Class A Common Stock4,528USD 48.49USD 219,561SEC filing ↗
2026-05-06BENDHEIM JACK; BFI Co., LLCSale (S)Class A Common Stock7,040USD 57.37USD 403,883SEC filing ↗
2026-05-05BENDHEIM JACK; BFI Co., LLCSale (S)Class A Common Stock7,040USD 55.80USD 392,836SEC filing ↗
2026-04-30BENDHEIM JACK; BFI Co., LLCSale (S)Class A Common Stock7,040USD 52.77USD 371,483SEC filing ↗
2026-04-29BENDHEIM JACK; BFI Co., LLCSale (S)Class A Common Stock7,040USD 52.92USD 372,557SEC filing ↗
2026-04-28BENDHEIM JACK; BFI Co., LLCSale (S)Class A Common Stock7,040USD 55.91USD 393,579SEC filing ↗
2026-04-23BENDHEIM JACK; BFI Co., LLCSale (S)Class A Common Stock7,040USD 54.10USD 380,859SEC filing ↗
2026-04-22BENDHEIM JACK; BFI Co., LLCSale (S)Class A Common Stock7,040USD 54.29USD 382,202SEC filing ↗
2026-04-21BENDHEIM JACK; BFI Co., LLCSale (S)Class A Common Stock7,040USD 55.98USD 394,104SEC filing ↗
2026-04-16BENDHEIM JACK; BFI Co., LLCSale (S)Class A Common Stock7,040USD 54.64USD 384,694SEC filing ↗
2026-04-16BENDHEIM JACK; BFI Co., LLCC (C)Class A Common Stock100,000USD 0.00USD 0SEC filing ↗
2026-04-15BENDHEIM JACK; BFI Co., LLCSale (S)Class A Common Stock7,040USD 56.96USD 401,012SEC filing ↗
2026-04-14BENDHEIM JACK; BFI Co., LLCSale (S)Class A Common Stock7,040USD 59.08USD 415,896SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerPAHC
CIK0001069899
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history167 transaction lines from 2021-02-08 to 2026-08-06
4 P purchase lines · 123 S sale lines · 40 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.